好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2015 Annual Meeting | 3MS.002 - Therapy of Epilepsy

Monday 04/20/15
06:30 AM - 08:00 AM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Morning Seminar
Carl W. Bazil, MD, PhD, FAAN
Participants should have greater familiarity with the properties of currently available AEDs, including the newest agents; how to choose the best first drug; and additional issues for refractory patients. Participants should also understand the role of newer AEDs in the treatment of refractory status epilepticus. The reasoning for early consideration of epilepsy surgery should be better understood, and participants should know how to identify and counsel the best candidates, in whom surgery is likely to be curative. Participants should also gain a better understanding of newer, less invasive approaches to epilepsy surgery.
1.50 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement
Trainee, General Neurologist, Specialist Neurologist
Case-based, Didactic, Interactive, Audience Participation
Event Timeline
06:30 AM - 07:10 AM Pharmacological Treatment of Epilepsy
Brien J. Smith, MD, FAAN
07:10 AM - 07:50 AM Non-pharmacological Treatment of Epilepsy
Carl W. Bazil, MD, PhD, FAAN
07:50 AM - 08:00 AM Questions and Answers
Faculty Disclosures
Carl W. Bazil, MD, PhD, FAAN Dr. Bazil has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medical Letter . Dr. Bazil has received publishing royalties from a publication relating to health care.
Brien J. Smith, MD, FAAN Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma.